Kidney transplantation in an elite HIV controller: Limited impact of immunosuppressive therapy on viro-immunological status

Journal of Infection

Volumn 64, Issue 6, 2012, Pages 630-633

  Lambotte, Olivier ^a,b,c   Lecuroux, Camille ^c   Saez Cirion, Asier ^d   Barbet, Christelle ^e   Shin, So Youn ^d   Boufassa, Faroudy ^f   Bastides, Frédéric ^e   Lebranchu, Yvon ^e  

^a BICÊTRE HOSPITAL   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c INSERM   (France)

^d INSTITUT PASTEUR   (France)

^e UNIVERSITÉ DE TOURS   (France)

^f INSTITUT NATIONAL D'ÉTUDES DÉMOGRAPHIQUES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIRETROVIRUS AGENT; BASILIXIMAB; CYCLOSPORIN A; FUROSEMIDE; METHYLDOPA; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; VIRUS RNA;

ANTIBODY DEPENDENT LYMPHOCYTOTOXICITY; CASE REPORT; CAUCASIAN; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LETTER; LIMIT OF DETECTION; LYMPHOCYTE COUNT; MEMORY T LYMPHOCYTE; SEXUALLY TRANSMITTED DISEASE; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANIMALS; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; HIV; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; KIDNEY TRANSPLANTATION; RENAL INSUFFICIENCY; VIRAL LOAD;

EID: 84860613924     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.03.001     Document Type: Letter

References (17)

1. Lambotte O., Boufassa F., Madec Y., Nguyen A., Goujard C., Meyer L., et al. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin Infect Dis 2005, 41(7):1053-1056.
2. Saez-Cirion A., Pancino G., Sinet M., Venet A., Lambotte O. HIV controllers: how do they tame the virus?. Trends Immunol 2007, 28(12):532-540.
3. Pereyra F., Addo M.M., Kaufmann D.E., Liu Y., Miura T., Rathod A., et al. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Dis 2008, 197(4):563-571.
4. *5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A 2000, 97(6):2709-2714.
5. Saez-Cirion A., Lacabaratz C., Lambotte O., Versmisse P., Urrutia A., Boufassa F., et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad Sci U S A 2007, 104(16):6776-6781.
6. Migueles S.A., Laborico A.C., Shupert W.L., Sabbaghian M.S., Rabin R., Hallahan C., et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 2002, 3(11):1061-1068.
7. Betts M.R., Nason M.C., West S.M., De Rosa S., Migueles S., Abraham J., et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006, 107(12):4781-4789.
8. Emu B., Sinclair E., Favre D., Moretto W., Hsue P., Hoh R., et al. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. J Virol 2005, 79(22):14169-14178.
9. Saez-Cirion A., Sinet M., Shin S.Y., Urrutia A., Versmisse P., Lacabaratz C., et al. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses. J Immunol 2009, 182(12):7828-7837.
10. Potter S.J., Lacabaratz C., Lambotte O., Perez-Patrigeon S., Vingert B., Sinet M., et al. Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study. J Virol 2007, 81:13904-13915.
11. Lambotte O., Ferrari G., Moog C., Yates N., Liao H., Parks R., et al. Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers. Aids 2009, 23(8):897-906.
12. Chen H., Li C., Huang J., Cung T., Seiss K., Beamon J., et al. CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21. J Clin Invest 2011, 121(4):1549-1560.
13. Saez-Cirion A., Hamimi C., Bergamaschi A., David A., Versmisse P., Mélard A., et al. Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers. Blood 2011, 118(4):955-964.
14. Schmitz J.E., Kuroda M.J., Santra S., Sasseville V., Simon M., Lifton M., et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999, 283(5403):857-860.
15. Ferre A.L., Hunt P.W., Critchfield J.W., Young D., Morris M., Garcia J., et al. Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. Blood 2009, 113(17):3978-3989.
16. Chapuis A.G., Paolo Rizzardi G., D'Agostino C., Attinger A., Knabenhans C., Fleury S., et al. Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo. Nat Med 2000, 6(7):762-768.
17. Hunt P.W., Brenchley J., Sinclair E., McCune J., Roland M., Page-Shafer K., et al. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis 2008, 197(1):126-133.